Regulation of sensitivity to 5-hydroxytryptamine in pulmonary supernumerary but not conventional arteries by a 5-HT(1D)-like receptor

European Journal of Pharmacology

Volumn 408, Issue 1, 2000, Pages 69-82

  Shaw, Angus M ^a   Bunton, David C ^a   Brown, Tracy ^a   Irvine, John ^a   MacDonald, Allan ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); 5 HT(1D) like receptor; Pulmonary supernumerary artery

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; 3 [4 (3 CHLOROPHENYL) 1 PIPERAZINYL] 1,1 DIPHENYL 2 PROPANOL; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 CARBAMOYLTRYPTAMINE; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; CYANOPINDOLOL; FORSKOLIN; METITEPINE; N [4 [5 [3 (2 AMINOETHYL) 1H INDOL 5 YL] 1,2,4 OXADIAZOL 3 YL]BENZYL]METHANESULFONAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; RITANSERIN; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2A RECEPTOR; SUMATRIPTAN;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REGULATORY MECHANISM; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADENYLATE CYCLASE; ANIMALS; CATTLE; FORSKOLIN; MUSCLE RELAXATION; PULMONARY ARTERY; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0034634364     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00757-3     Document Type: Article

References (41)

1. 1 receptor subtype coupled to the inhibition of adenylyl cyclase
2. 8-Hydroxy-2-(di-n-propylamino)tetralin - Responsive 5-hydroxytryptamine-4-like receptor expressed in bovine pulmonary artery smooth muscle cells
3. L-964,247: A potent 5-HT(1D) receptor agonist
4. 5-HT(1D)-like receptor in bovine pulmonary supernumerary arteries
5. Receptor subtypes for 5-HT in bovine pulmonary supernumerary arteries
6. 5-Hydroxytryptamine- and U46619-mediated vasoconstriction in bovine pulmonary conventional and supernumerary arteries
7. Evolution of a novel series of [(N,N-dimethylaminno)propyl]- and piperazinylbenzanilides as the first selective 5-HT(1D) antagonists
8. DOI and α-methylserotonin: Comparative vascular and nonvasculature smooth muscle effects and central 5-hydroxytryptamine-2 receptor affinities
9. 2 receptor agonist in the rat
10. The serotonin-S2 receptor: A receptor-transducer coupling model to explain insurmountable antagonistic effects
11. Some new facts about the pulmonary artery and its branching pattern
12. 2 receptors in pulmonary and coronary arteries of calf
13. 2 receptor system of the rat tail artery-ritanserin and methysergide are not competitive antagonists but allosteric modulators
14. Allosteric properties of the 5-HT receptors system of the rat tail artery
15. The selective 5-HT(1B) receptor inverse agonist 1'-Methyl-5-[[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)bipheny l-4-yl]carbonyl]-2,3,6,7,-tetrahydrospiro[furo[2,3-f]indole-3,4'- piperidine] (SB224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo
16. 2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogs
17. 2 serotonin receptors
18. Human serotonin receptor clone encodes a 5-hydroxytryptamine(1E)-like serotonin receptor
19. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
20. A proposed new nomenclature for 5-HT receptors
21. 2-like receptors. Can they be classified with the available antagonists?
22. Quantification of the actions of 5-hydroxytryptamine receptor agonists and antagonists
23. The effect of ketanserin on serotonin-induced vascular responses in the isolated perfused rat lung
24. Molecular cloning of a human gene (S31) encoding a novel serotonin receptor mediating inhibition of adenylyl cyclase
25. 3H] alniditan
26. Pulmonary hypertension, anorexigens and 5-HT: Pharmacological synergism in action
27. 1-receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: Influence of vascular endothelium and tone
28. 5-hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats
29. 2 receptor antagonism
30. 1-like subtype
31. Centrally active agonists and antagonists
32. 5-Hydroxtryptamine receptors mediating vasconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries
33. Structure and pathogenesis of plexiform lesions in pulmonary hypertension
34. Pharmacological properties of a putative 5-HT(1B/1D) receptor antagonist GR127935
35. Sumatriptan (GR43175) interacts selectively with 5-HT(1B) and 5-HT(1D) binding sites
36. SB-216641 and BRL15572-compounds to pharmacologically discriminate h5-HT(1B) and h5-HT(1D) receptors
37. Structural remodelling of the pulmonary vasculature by environmental change and disease
38. V-shaped cushion at the origin of bovine pulmonary supernumerary arteries: Structure and putative function
39. GR127935: A potent and selective 5-HT(1D) receptor antagonist
40. The subtype of serotonin (5-HT) receptors in the rat pulmonary artery
41. Distribution of arterial lesions and collateral pathways in the pulmonary hypertension of congenital heart disease: A computer-aided reconstruction study